KURE ETF (KraneShares MSCI All China Health Care Index ETF) is managed by KraneShares with $82.5M in net assets. KURE expense ratio is 0.65%, holding 55 positions across sectors including Unknown, Health Care, Information Technology. Inception date: 2018-01-31.

KURE performance shows a YTD return of 1.96%. The 1-year return is 17.76% and the 5-year return is -12.41%. KURE dividend yield stands at 4.04%, paid annually.

KURE top holdings include Beigene Ag (9.7%), Jiangsu Hengrui Medicine Co Ltd (8.0%), Innovent Biologics Inc (7.5%), Wuxi Biologics (cayman) Inc Usd0.000025 (7.5%), Shenzhen Mindray Bio-Medical Electronics Co Ltd (4.5%). View all KURE holdings, sector breakdown, or dividend history.

KURE can be compared against other funds using the overlap calculator or side-by-side comparison tool. KURE alternatives are available via the screener, along with tax-loss harvesting opportunities.